This article was originally published in The Gray Sheet
Cardiopulmonary bypass accessory equipment (21 CFR 870.4200) that involves an electrical connection to the patient, goniometer devices (888.1500) and electrode cables (890.1175) would be reclassified from Class I to Class II under an Aug. 9 FDA proposed rule. The products likewise would be exempted from 510(k) requirements, FDA says. Cardiopulmonary bypass accessory equipment that does not involve electrical connection to the patient would remain in Class I and be 510(k)-exempt. Special controls for all three devices would be FDA's performance standard for electrode lead wire and patient cables and the agency's guidance document for complying with the standard. Comments on the proposal are due Nov. 8
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.